FDA Approves RSV Vaccine for Pregnant Individuals to Prevent Virus in Infants
The respiratory syncytial virus (RSV) vaccine Abrysvo is approved for use in pregnant individuals to prevent the RSV in infants up to 6 months of age.
United States Ericaf Sim Annaliesa Anderson Study Group Bivalent Vaccine Research University Of Colorado School Medicine
Source: ajmc.com